Article Versions Notes

Ishibashi K, Fujita M, Takano Y, Iwai H, Inanami H, Koga H. Chemonucleolysis with Chondroitin Sulfate ABC Endolyase for Treating Lumbar Disc Herniation: Exploration of Prognostic Factors for Good or Poor Clinical Outcomes. Medicina. 2020; 56(11):627. https://doi.org/10.3390/medicina56110627

Ishibashi, Katsuhiko, Muneyoshi Fujita, Yuichi Takano, Hiroki Iwai, Hirohiko Inanami, and Hisashi Koga. 2020. "Chemonucleolysis with Chondroitin Sulfate ABC Endolyase for Treating Lumbar Disc Herniation: Exploration of Prognostic Factors for Good or Poor Clinical Outcomes" Medicina 56, no. 11: 627. https://doi.org/10.3390/medicina56110627

Ishibashi, K., Fujita, M., Takano, Y., Iwai, H., Inanami, H., & Koga, H. (2020). Chemonucleolysis with Chondroitin Sulfate ABC Endolyase for Treating Lumbar Disc Herniation: Exploration of Prognostic Factors for Good or Poor Clinical Outcomes. Medicina, 56(11), 627. https://doi.org/10.3390/medicina56110627